Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05RWD
|
||||
Former ID |
DIB002984
|
||||
Drug Name |
Research programme: farnesoid X receptor agonists, Roche
|
||||
Synonyms |
Farnesoid X receptor agonists (dyslipidemia/diabetes); FXR agonists (dyslipidemia/ diabetes), Roche; Farnesoid X receptor agonists (dyslipidemia/diabetes), Roche
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Investigative | [543895] | ||
Company |
Roche Holding AG
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c(cc2c(c1)nc(n2[C@H](C(=O)Nc1ccc(cc1F)C(=O)O)C1CCCCC<br />1)c1ccc(cc1)Cl)F)F
|
||||
Target and Pathway | |||||
Target(s) | Bile acid receptor | Target Info | Agonist | [543895] | |
KEGG Pathway | Bile secretion | ||||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.